CHONG KUN DANG
CKD Pharm. which was founded in 1941 with a motto "Better life through better medicine" has been developed one of Korean representative companies.
CKD newly launched novel anti-cancer drug "CAMTOBELL inj.(Belotecan)" in 2003
and will develop novel anti-diabetic drug(Lobeglitazone) in 2015.
Booth No. D009
Exhibition Item
PREGREL
Satellite Symposium
| Morning Roundtable Forum: Meet the Experts over Breakfast |
| Antithrombotic Therapy: Finding the “Sweet-Spot” |
| Organized by CVRF and Supported by Educational Grant from Chong Kun Dang Pharm. |
Wednesday, April 26
7:00 AM - 8:10 AM
Room 105, Level 1 |
| Moderator(s): David Joel Cohen, Freek W.A. Verheugt |
| Panelist(s): Barakath Badusha Abdul Kareem, Junya Ako, Francisco Jose Ayala Riquelme, Davide Capodanno, Byung Ryul Cho, Joo-Yong Hahn, Kyoo-Rok Han, Dong Woon Jeon, Adnan Kastrati, Chung-Pin Liu, Prakas Chandra Mondal, Yoshiki Nagata, Kyung Woo Park, Huay Cheem Tan |
|
| What We Know |
| 7:00 AM |
ACS and DAPT Duration: Which One and How Long? |
| What We Want to Know |
| 7:15 AM |
Atrial Fibrillation & PCI: Many Regimens, Little Solutions! |
| 7:30 AM |
DAPT After BRS Implantation: The Longer the Better? |
| 7:45 AM |
Panel Discussion
|
